Home βΊ Calculator βΊ RCUS Dividend Calculator 2026
RCUS Dividend DRIP Calculator 2026
6.59% YieldHealthcareArcus Biosciences, Inc. Β· NYSE
Price: $30.33 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
π‘ What-if scenarios
Click to apply scenario to the calculator
π― When RCUS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your RCUS snowball π
$10,000 in RCUS β $1.34M in 10 years Β· $61.00/month
About Arcus Biosciences, Inc. (RCUS) β Dividend Analysis 2026
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The companyβs development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.
Compare RCUS with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RCUS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open RCUS position with:
π RCUS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RCUS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 6.59% | 3.79% | $659 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 5.60% | 2.80% | $560 / yr |
| πΊπΈ US Taxable (20%) | 20% | 5.27% | 2.47% | $527 / yr |
| π¬π§ UK ISA | 0% | 6.59% | 3.79% | $659 / yr |
| π¬π§ UK Taxable | 8.75% | 6.01% | 3.21% | $601 / yr |
| π¨π¦ TFSA | 0% | 6.59% | 3.79% | $659 / yr |
| π¨π¦ CA Taxable | 25% | 4.94% | 2.14% | $494 / yr |
| π¦πΊ Super (pension) | 15% | 5.60% | 2.80% | $560 / yr |
| π¦πΊ AU Taxable | 30% | 4.61% | 1.81% | $461 / yr |
| π©πͺ DE Taxable | 26.375% | 4.85% | 2.05% | $485 / yr |
| π«π· FR Taxable | 30% | 4.61% | 1.81% | $461 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― RCUS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π RCUS Dividend Payment Schedule
RCUS pays quarterly β 4 times per year. Next ex-div: TBD.
π RCUS vs Healthcare Benchmarks
How RCUS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RCUS sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ RCUS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-07-09 | 48,502 | $30.05 | $1.46M | ||
| Sale | 2026-07-10 | 19,799 | $28.61 | $566.4K | ||
| Sale | 2026-07-10 | 268 | $29.40 | $7.9K | ||
| Sale | 2026-06-22 | 9,236 | $27.03 | $249.7K | ||
| Sale | 2026-06-23 | 14,067 | $27.69 | $389.5K | ||
| Sale | 2026-06-23 | 1,697 | $28.06 | $47.6K | ||
| Sale | 2026-06-24 | 6,431 | $29.66 | $190.7K | ||
| A-Award | 2026-06-11 | 5,700 | β | β | ||
| A-Award | 2026-06-11 | 16,900 | $23.30 | $393.8K | ||
| A-Award | 2026-06-11 | 5,700 | β | β |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RCUS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Arcus Biosciences, Inc. (RCUS) is currently trading at $30.33, 30% below its 52-week high. The current dividend yield is 6.59% based on an annual payout of $2.00 per share.
RCUS (Arcus Biosciences, Inc.) β 6.59% Dividend Yield Analysis
Arcus Biosciences, Inc. (RCUS) is a healthcare stock currently trading at $30.33 with a dividend yield of 6.59%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only β not financial advice.